ED-SAFE Patient Safety Screener 3 (PSS-3)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
pss3 result
—status
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Negative Screen0–0
  • Positive Screen1–1
Direct Clinical Answer

The ED-SAFE Patient Safety Screener 3 (PSS-3) calculates rapid bedside triage, risk stratification, and urgent clinical decision-making. Key inputs include depression past 2 weeks. Scores guide determining acute hospital admission, emergency department discharge safety, or intensive care transfer. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Screens for suicidality in emergency patients through universal screening with a validated 3-question tool. Designed for rapid assessment of suicide risk in the emergency department setting for patients with any chief complaint.

Clinical Indication

The ED-SAFE Patient Safety Screener 3 (PSS-3) is indicated for bedside clinical practice to support Screens for suicidality in emergency patients through universal screening with a validated 3-question tool. Designed for rapid assessment of suicide risk in the emergency department setting for patients with any chief complaint.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.

Limitations & Contraindications

Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.

Clinical Pearls & Action Plan

Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools. Guideline pearl: Validation study demonstrated fair agreement for ideation detection (κ = 0.61) and excellent agreement for suicide attempts (κ = 0.97-0.98)..

Formula & Variables:

PSS-3 positive screening if: (1) Active suicidal ideation in past 2 weeks (Question 2 = Yes) OR (2) Lifetime history of suicide attempt (Question 3 = Yes). Depression question (Question 1) contributes to clinical context but does not independently determine positive screening.

Input Parameters

NameTypeRequiredDescription
depression_past_2_weeksstringYesOver the past 2 weeks, have you felt down, depressed, or hopeless?
suicidal_thoughts_past_2_weeksstringYesOver the past 2 weeks, have you had thoughts of killing yourself?
lifetime_suicide_attemptstringYesHave you ever in your lifetime made a suicide attempt?

Score Interpretation & Guidance

RangeStageDescription
0–0Negative ScreenNo current suicide risk indicators
1–1Positive ScreenPositive for suicide risk indicators

Evidence-Based References (EBM)

  • Boudreaux ED, Camargo CA Jr, Arias SA, Blais RK, Horton BJ, Jaques ML, et al. Improving Suicide Risk Screening and Detection in the Emergency Department. Am J Prev Med. 2016;50(4):445-453. doi: 10.1016/j.amepre.2015.09.029.DOI: 10.1016/j.amepre.2015.09.029
  • Boudreaux ED, Jaques ML, Brady KM, Matson A, Allen MH. The patient safety screener: validation of a brief suicide risk screener for emergency department settings. Arch Suicide Res. 2015;19(2):151-60. doi: 10.1080/13811118.2015.1034604.DOI: 10.1080/13811118.2015.1034604
  • Miller IW, Camargo CA Jr, Arias SA, Sullivan AF, Allen MH, Goldstein AB, et al. Suicide prevention in an emergency department population: the ED-SAFE study. JAMA Psychiatry. 2017;74(6):563-570. doi: 10.1001/jamapsychiatry.2017.0678.DOI: 10.1001/jamapsychiatry.2017.0678
  • Boudreaux ED, Miller I, Goldstein AB, Sullivan AF, Allen MH, Manton AP, et al. The Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE): method and design considerations. Contemp Clin Trials. 2013;36(1):14-24. doi: 10.1016/j.cct.2013.05.008.DOI: 10.1016/j.cct.2013.05.008

Related calculators